{"url_path":"/register/2026-06-24/2026-12653","section_key":"summary","section_title":"Schedules of Controlled Substances: Placement of Bromazolam in Schedule I; Correction","topic":"register","document":{"doc_type":"Rule","doc_date":"2026-06-24","source_url":"https://www.federalregister.gov/documents/2026/06/24/2026-12653/schedules-of-controlled-substances-placement-of-bromazolam-in-schedule-i-correction","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Justice Department"},"word_count":100,"has_tables":false,"body_markdown":"# Schedules of Controlled Substances: Placement of Bromazolam in Schedule I; Correction\n\n**Type:** Rule\n**Published:** 2026-06-24\n**Effective:** 2026-06-24\n**Citation:** 91 FR 37821\n**Agencies:** Justice Department, Drug Enforcement Administration\n**Source:** https://www.federalregister.gov/documents/2026/06/24/2026-12653/schedules-of-controlled-substances-placement-of-bromazolam-in-schedule-i-correction\n\n## Abstract\nOn March 16, 2026, the Drug Enforcement Administration published a temporary order placing 8-bromo-1-methyl-6-phenyl-4H- benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine (commonly known as bromazolam), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers are possible, in schedule I of the Controlled Substances Act. DEA published this temporary order that included an invalid chemical name for bromazolam. This document corrects that error, adding the valid chemical name for bromazolam."}